Estriol assay

Claim 2

In an immunoassay for determining the presence of estriol in samples of human sera, said assay depending on binding between the estriol and a specific binding protein in an assay medium, an improvement comprising adding to the assay medium predetermined amounts of both a polyoxyethylene ether and a surface active agent selected from the group consisting of polyoxyethylenesorbitans, deoxycholate salts, and ANS, said predetermined amounts selected to inhibit protein interference with the specific binding between the estriol and specific binding protein.

Claim 3

An immunoassay for determining the presence of estriol in a sample of human sera, the assay involving competitive binding between the estriol and a labeled estriol analog to an immobilized binding protein specific for estriol, said assay comprising: combining in an aqueous assay medium, the sample, the labeled estriol analog and the immobilized binding protein in the presence of sufficient amounts of a polyoxyethylene ether and a surface active agent selected from the group consisting of polyoxyethylenesorbitans, deoxycholate salts, and ANS so as to prevent protein interference with specific binding between the binding protein and the labeled estriol analog; incubating the mixture for a sufficient time to allow specific binding of the estriol and labeled estriol to the immobilized binding protein; separating the immobilized binding protein from the assay medium; and detecting the amount of labeled estriol bound to the immobilized binding protein or the amount remaining unbound in the assay medium.

Claim 4

An immunoassay for determining the presence of estriol in a sample of human sera, the assay involving competitive binding between the estriol and a labeled estriol analog to an immobilized binding protein specific for estriol, said assay comprising: combining in an aqueous assay medium, the sample, the labeled estriol analog and the immobilized binding protein in the presence of sufficient amounts of a polyoxyethylene ether and a surface active agent selected from the group consisting of polyoxyethylenesorbitans, deoxycholate salts, and ANS so as to prevent protein interference with specific binding between the binding protein and the labeled estriol analog; incubating the mixture for a sufficient time to allow specific binding of the estriol and labeled estriol to the immobilized binding protein; separating the immobilized binding protein from the assay medium; and detecting the amount of labeled estriol bound to the immobilized binding protein or the amount remaining unbound in the assay medium.

Claim 5

An immunoassay assay as in claims 1 or 2, wherein the polyoxyethylene ether is added to a final concentration in the range from about 30 to 1500μg/ml and the surface active agent is ANS added to a final concentration of from about 1 to 100μg/ml of assay medium.

Claim 6

An immunoassay as in claims 1 or 2, wherein the polyoxyethylene ether is added to a final concentration in the range from about 30 to 1500μg/ml and the surface active agent is either a polyoxyethylenesorbitan or a deoxycholate salt added to a final concentration of from about 100 to 5000μg/ml.

Claim 7

An immunoassay as in claims 1 or 2, wherein the polyoxyethylene ether is added to a final concentration in the range from about 270 to 330μg/ml and the surface active agent is ANS added to a final concentration of from about 10 to 25μg/ml of assay medium.

Claim 8

An immunoassay as in claims 1 or 2, wherein the polyoxyethylene ether is added to a final concentration in the range from about 270 to 330μg/ml and the surface active agent is either a polyoxyethylenesorbitan or a deoxycholate salt added to a final concentration of from about 500 to 2500μg/ml.

Claim 9

An immunoassay as in claims 1 or 2, wherein the labeled estriol, polyoxyethylene ether and surface active agent are combined in a tracer solution prior to addition to the assay medium.

Claim 10

An immunoassay as in claims 1 or 2, wherein the polyoxyethylene ether is selected from the group consisting of lauryl ether, cetyl ether, oleyl ether, stearyl ether, and tridecyl ether.

Claim 11

An immunoassay as in claims 1 or 2, wherein the polyoxyethylenesorbitans are selected from the group consisting of polyoxyethylenesorbitan mono-oleate, polyoxyethylenesorbitan mono-palmitate, polyoxyethylenesorbitan mono-stearate, and polyoxyethylenesorbitan trioleate.

Claim 12

A kit for performing an immunoassay to determine the presence of estriol in human sera, said kit comprising: a tracer comprising radioactively labelled estriol; a reagent comprising a binding protein specific for estriol immobilized on polymeric particles; sufficient amounts of a polyoxyethylene ether and a surface active agent selected from the group consisting of polyoxyethylenesorbitans, deoxycholate salts, and ANS to inhibit protein interference in performing the assay when added to the assay medium; and a container for holding said tracer, reagent, and polyoxyethylene ether and surface active agent, where the tracer and reagent are stored separately.

Claim 13

A kit for performing an immunoassay to determine the presence of estriol in human sera, said kit comprising: a tracer comprising radioactively labelled estriol; a reagent comprising a binding protein specific for estriol immobilized on polymeric particles; sufficient amounts of a polyoxyethylene ether and a surface active agent selected from the group consisting of polyoxyethylenesorbitans, deoxycholate salts, and ANS to inhibit protein interference in performing the assay when added to the assay medium; and a container for holding said tracer, reagent, and polyoxyethylene ether and surface active agent, where the tracer and reagent are stored separately.

Claim 14

A kit as in claim 10, wherein the polyoxyethyleneether and surface active agent are combined with the tracer.

Claim 15

A kit as in claim 10, wherein the polyoxyethylene ether is selected from the group consisting of lauryl ether, cetyl ether, oleyl ether, stearyl ether, and tridecyl ether.

Claim 16

A kit as in claim 10, wherein the polyoxyethylenesorbitans are selected from the group consisting of polyoxyethylenesorbitan mono-oleate, polyoxyethylenesorbitan mono-palmitate, polyoxyethylenesorbitan mono-stearate, and polyoxyethylenesorbitan trioleate.

Claim 17

A kit as in claim 10, wherein the polyoxyethylene ether is 23 lauryl ether and the surface active agent is polyoxyethylenesorbitan mono-oleate.

Claim 18

A kit as in claim 10, wherein the polyoxyethylene ether is 23 lauryl ether and the surface active agent is sodium deoxycholate.

Claim 19

A kit as in claim 10, wherein the polyoxyethylene ether is 23 lauryl ether and the surface active agent is ANS.

Claim 20

A kit as in claim 10, wherein the tracer and specific binding protein are present in separate buffer solutions.

Claim 21

A kit as in claim 10, wherein the tracer and receptor are lyophilized.